Prevalence and Risk Factors in a Sample Population of Hemiplegia—An Observational Study
DOI:
https://doi.org/10.37591/rrjom.v9i2.1718Abstract
Falij is the paralysis of longitudinal half of the body starting either below the neck, sparing head and face or covering the entire longitudinal half of the body from head to toe. It draws analogy with hemiplegia occurring due to stroke. Unani system of medicine asserts to possess treatment for motor recovery in Falije Nisfi. Almost all ancient Unani physicians have advocated Tanqia and Ta’deel as treatment of Falij caused by BalghamiKhilt. Patients of hemplasia who attended the OPD/IPD, Department of Moalijat, Jamia Tibbya Deoband, Saharanpur, India were thoroughly enquired and examined. The highest incidence of 61 (61%) patients was observed in lower middle class followed by 24 (24%) patients in upper lower class. As shown by age distribution of the patient, 49% patients were in the age group of 61–70 years. Male predominance was seen in 89% cases. Out of 100 patients, 81 (81%) patients followed mixed dietary habit and 19 (19%) patients did vegetarian. The most prevalent among the risk factors in this study was smoking in 51 (51%) cases, followed by hypertension present in 47 (47%) patients. A maximum of 91 (91%) patients were found having Balghami mizaj followed by nine (9%) patients having Damvi. Unani physicians have treated Falij-e-Nisfi effectively since ancient times on the principles of Tanqia and Ta’deel; however, various drugs combinations and regimenal procedures as a comprehensive treatment have not been scientifically validated through clinical trials.
Keywords: Falij-e-Nisfi, hemiplegia, Tanqia
Cite this Article
Humera Kausar, Shah Fasal, Junaid Nazir Dandroo, Rehana Alvi. Prevalence and Risk Factors in a Sample Population of Hemiplegia—An Observational Study. Research & Reviews: Journal of Medicine. 2019; 9(2): 25–29p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |